This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2019.
Company Filing History:
1 out of 29 
1 out of 5,383 
1 out of 1,853 
Years Active: 2019
Title: Adrien Guerard: Innovator in Prostate Cancer Treatment
Introduction
Adrien Guerard is a notable inventor based in Toulouse, France. He has made significant contributions to the field of medical research, particularly in the treatment and diagnosis of prostate cancer. His innovative work has the potential to impact the lives of many patients suffering from this disease.
Latest Patents
Adrien Guerard holds a patent for the invention titled "Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer." This invention focuses on an inhibitor of the expression of chemokine CCL7 or the receptor CCR3, or an inhibitor of the CCL7/CCR3 interaction. The goal is to prevent or treat the extension of prostate cancer outside the prostatic capsule in a subject. Additionally, the invention includes a method for determining the degree of aggressiveness of a prostate cancer tumor by assessing the concentration or level of expression of the receptor CCR3 in a sample of prostate tumor cells obtained from the subject. This patent represents a significant advancement in the fight against prostate cancer.
Career Highlights
Throughout his career, Adrien Guerard has worked with esteemed institutions such as Université Paul Sabatier (Toulouse III) and the Centre National de la Recherche Scientifique. His research has been pivotal in understanding the mechanisms of prostate cancer and developing targeted therapies.
Collaborations
Adrien has collaborated with notable colleagues, including Catherine Muller and Victor Laurent. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Adrien Guerard's contributions to the field of prostate cancer treatment through his innovative patent and collaborative efforts highlight his dedication to advancing medical science. His work continues to inspire future research and development in oncology.